Does migration affect asthma, rhinoconjunctivitis and eczema prevalence? Global findings from the international study of asthma and allergies in childhood.

Saved in:
Bibliographic Details
Title: Does migration affect asthma, rhinoconjunctivitis and eczema prevalence? Global findings from the international study of asthma and allergies in childhood.
Authors: Garcia-Marcos L; Respiratory Medicine and Allergy Units, Virgen de la Arrixaca University Children's Hospital, University of Murcia, Murcia, Spain, Murdoch Children's Research Institute, Melbourne, Australia, MRC Centre for Environment and Health, St George's, University of London, London, UK, Department of Paediatrics: Child and Youth Health, University of Auckland, Auckland, New Zealand, Centre of Evidence-Based Dermatology, University of Nottingham, Nottingham, UK and Department of Paediatrics, Prince of Wales Hospital, Chinese University of Hong Kong, Shatin, Hong Kong Special Administrative Region, China. The ISAAC Phase Three Study group are listed under Supplementary data at IJE online lgmarcos@um.es., Robertson CF; Respiratory Medicine and Allergy Units, Virgen de la Arrixaca University Children's Hospital, University of Murcia, Murcia, Spain, Murdoch Children's Research Institute, Melbourne, Australia, MRC Centre for Environment and Health, St George's, University of London, London, UK, Department of Paediatrics: Child and Youth Health, University of Auckland, Auckland, New Zealand, Centre of Evidence-Based Dermatology, University of Nottingham, Nottingham, UK and Department of Paediatrics, Prince of Wales Hospital, Chinese University of Hong Kong, Shatin, Hong Kong Special Administrative Region, China. The ISAAC Phase Three Study group are listed under Supplementary data at IJE online., Ross Anderson H; Respiratory Medicine and Allergy Units, Virgen de la Arrixaca University Children's Hospital, University of Murcia, Murcia, Spain, Murdoch Children's Research Institute, Melbourne, Australia, MRC Centre for Environment and Health, St George's, University of London, London, UK, Department of Paediatrics: Child and Youth Health, University of Auckland, Auckland, New Zealand, Centre of Evidence-Based Dermatology, University of Nottingham, Nottingham, UK and Department of Paediatrics, Prince of Wales Hospital, Chinese University of Hong Kong, Shatin, Hong Kong Special Administrative Region, China. The ISAAC Phase Three Study group are listed under Supplementary data at IJE online., Ellwood P; Respiratory Medicine and Allergy Units, Virgen de la Arrixaca University Children's Hospital, University of Murcia, Murcia, Spain, Murdoch Children's Research Institute, Melbourne, Australia, MRC Centre for Environment and Health, St George's, University of London, London, UK, Department of Paediatrics: Child and Youth Health, University of Auckland, Auckland, New Zealand, Centre of Evidence-Based Dermatology, University of Nottingham, Nottingham, UK and Department of Paediatrics, Prince of Wales Hospital, Chinese University of Hong Kong, Shatin, Hong Kong Special Administrative Region, China. The ISAAC Phase Three Study group are listed under Supplementary data at IJE online., Williams HC; Respiratory Medicine and Allergy Units, Virgen de la Arrixaca University Children's Hospital, University of Murcia, Murcia, Spain, Murdoch Children's Research Institute, Melbourne, Australia, MRC Centre for Environment and Health, St George's, University of London, London, UK, Department of Paediatrics: Child and Youth Health, University of Auckland, Auckland, New Zealand, Centre of Evidence-Based Dermatology, University of Nottingham, Nottingham, UK and Department of Paediatrics, Prince of Wales Hospital, Chinese University of Hong Kong, Shatin, Hong Kong Special Administrative Region, China. The ISAAC Phase Three Study group are listed under Supplementary data at IJE online., Wong GW; Respiratory Medicine and Allergy Units, Virgen de la Arrixaca University Children's Hospital, University of Murcia, Murcia, Spain, Murdoch Children's Research Institute, Melbourne, Australia, MRC Centre for Environment and Health, St George's, University of London, London, UK, Department of Paediatrics: Child and Youth Health, University of Auckland, Auckland, New Zealand, Centre of Evidence-Based Dermatology, University of Nottingham, Nottingham, UK and Department of Paediatrics, Prince of Wales Hospital, Chinese University of Hong Kong, Shatin, Hong Kong Special Administrative Region, China. The ISAAC Phase Three Study group are listed under Supplementary data at IJE online.
Corporate Authors: ISAAC Phase Three Study Group
Source: International journal of epidemiology [Int J Epidemiol] 2014 Dec; Vol. 43 (6), pp. 1846-54. Date of Electronic Publication: 2014 Jul 23.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 7802871 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1464-3685 (Electronic) Linking ISSN: 03005771 NLM ISO Abbreviation: Int J Epidemiol Subsets: MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first